Safety of hormone replacement therapy in women with a history of cervical adenocarcinoma
This retrospective cohort study assessed the impact of hormone replacement therapy (HRT) on survival outcomes in women under 50 treated for stage IB-IIB cervical adenocarcinoma. The study analyzed 58 patients divided into three groups: ovaries conserved (OVCON), iatrogenic menopause with HRT (IM-HRT), and iatrogenic menopause without HRT (IM-NOHRT). Five-year disease-specific
June 26, 2025
No Comments